BeiGene Ltd (BGNE)
167.92
+0.53
(+0.32%)
USD |
NASDAQ |
May 22, 16:00
167.53
-0.39
(-0.23%)
After-Hours: 20:00
BeiGene Free Cash Flow: -1.566B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.566B |
| December 31, 2023 | -1.754B |
| September 30, 2023 | -1.853B |
| June 30, 2023 | -2.283B |
| March 31, 2023 | -2.298B |
| December 31, 2022 | -1.966B |
| September 30, 2022 | -2.144B |
| June 30, 2022 | -2.016B |
| March 31, 2022 | -2.044B |
| December 31, 2021 | -1.614B |
| September 30, 2021 | -1.334B |
| June 30, 2021 | -1.193B |
| March 31, 2021 | -1.030B |
| December 31, 2020 | -1.510B |
| September 30, 2020 | -1.426B |
| June 30, 2020 | -1.301B |
| March 31, 2020 | -1.093B |
| Date | Value |
|---|---|
| December 31, 2019 | -908.88M |
| September 30, 2019 | -883.72M |
| June 30, 2019 | -746.96M |
| March 31, 2019 | -787.16M |
| December 31, 2018 | -688.55M |
| September 30, 2018 | -336.26M |
| June 30, 2018 | -189.32M |
| March 31, 2018 | -127.08M |
| December 31, 2017 | -45.98M |
| September 30, 2017 | -154.99M |
| June 30, 2017 | -173.76M |
| March 31, 2017 | -132.97M |
| December 31, 2016 | -113.02M |
| September 30, 2016 | -99.00M |
| June 30, 2016 | -78.78M |
| March 31, 2016 | -61.36M |
| December 31, 2015 | -45.16M |
Free Cash Flow Range, Past 5 Years
-2.298B
Minimum
Mar 2023
-746.96M
Maximum
Jun 2019
-1.548B
Average
-1.538B
Median
Free Cash Flow Benchmarks
| Theravance Biopharma Inc | -18.44M |
| LumiraDx Ltd | -140.52M |
| Dr Reddy's Laboratories Ltd | 217.41M |
| ASLAN Pharmaceuticals Ltd | -- |
| Jazz Pharmaceuticals PLC | 983.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -308.57M |
| Cash from Investing (Quarterly) | -209.83M |
| Cash from Financing (Quarterly) | 162.29M |
| Free Cash Flow Per Share (Quarterly) | -4.811 |
| Free Cash Flow to Equity (Quarterly) | -641.63M |
| Free Cash Flow to Firm (Quarterly) | -501.62M |
| Free Cash Flow Yield | -8.88% |